Sharon Rogers

CEO

Sharon brings the strength behind 35 years of pharma experience to AmyriAD. She is best known as the worldwide leader and development strategist for the highly successful AD treatment, Aricept. Aricept has been the standard of care for more than 20 years and no other AD program has produced more compelling results.

Sharon has perspectives from large-cap to VC-incubated companies. Her first start-up was Eisai’s fledgling US subsidiary. She rose to VP of CR&D and later extended her reach at Eisai’s Tokyo headquarters as Global Director of Strategic Portfolio Management and Vice Chair of the Global Clinical Committee. Upon returning from Japan, she moved to VC-based start-ups holding a variety of senior executive positions, including CEO, CMO and President.

Sharon earned her B.A. from Capital University and a Ph.D. from the Ohio State University College of Medicine, School of Biomedical Sciences. She has been a lifetime entrepreneur, starting her first enterprise while still in graduate school. Outside of business, she enjoys cycling and long-distance running, with over a dozen marathons under her belt. She also has served the United States as a distinguished Olympic and World Championship judge of Figure Skating.